1. HISTORY
==========

A 55-year-old woman was diagnosed with breast adenocarcinoma in August 2006. In late September, she complained of back pain and slight numbness. A bone scan revealed a mild increase in activity in the thoracic spine and the proximal fourth and anterior sixth ribs. Magnetic resonance imaging ([mri]{.smallcaps}) of the spine confirmed metastatic involvement in the tenth thoracic vertebra. The patient received radiotherapy with 20 Gy in 5 fractions in October 2006. She tolerated the treatment very well with complete pain relief.

The woman returned to her medical oncologist for systemic therapy. A combination of paclitaxel (175 mg/m^2^) and gemcitabine (1000 mg/m^2^) was commenced in November 2006. After receiving a single dose, the patient complained of double vision. A computed tomography examination confirmed left orbital metastases ([Figure 1](#f1-co15_1p053){ref-type="fig"}) and multiple intraparenchymal brain metastases in the left frontal lobe and left cerebellum. The woman was treated with whole-brain radiotherapy ([wbrt]{.smallcaps}), including the left orbit, which received a dose of 20 Gy in 5 fractions. The initial chemotherapy treatment took place 13 days before the commencement of the [wbrt]{.smallcaps}. No adverse reactions were observed immediately after the radiation treatment.

Ten days after completion of the [wbrt]{.smallcaps}, the patient received her second dose of paclitaxel and gemcitabine. Within 2 days, the patient detected discoloured and inflamed skin limited to the region that had previously been irradiated. She also experienced swelling in the left ear, muffled hearing, and discomfort in the eyes as a result of the reaction. Surprisingly, increased pigmentation also occurred in the area of the thoracic bone metastases treated with palliative radiotherapy approximately 7 weeks earlier. Silver sulphadiazine cream and hydrocortisone eardrops were prescribed to treat external symptoms. All chemotherapy was put on hold.

Approximately 4 weeks after development of the skin reaction, the patient developed new cervical nodes compatible with clinical progression of her breast cancer. Once the external skin reaction had improved significantly, with only mild discolouration remaining, chemotherapy was resumed. At this time, nearly 6 weeks had passed since the appearance of the radiation recall dermatitis ([rrd]{.smallcaps}). A chemotherapy regimen of cyclophosphamide (600 mg/m^2^), epirubicin (100 mg/m^2^), and 5-fluorouracil (600 mg/m^2^) replaced the paclitaxel and gemcitabine. Dexamethasone (Decadron: Merck, Whitehouse Station, NJ, U.S.A) was administered at 20 mg before the first chemotherapy treatment and at 10 mg before each subsequent treatment. No adverse reactions have occurred since. At follow-up, the patient's double vision had improved, and a computed tomography scan revealed a stable appearance in the orbital metastases. New [mri]{.smallcaps} examination of the brain, orbits, and spine revealed no demyelination corresponding to the areas affected by the [rrd]{.smallcaps} reaction.

2. DISCUSSION
=============

"Radiation recall"---also called [rrd]{.smallcaps}---is defined as the "recalling" by skin of previous radiation exposure in response to the administration of certain response-inducing drugs [@b1-co15_1p053]. In the medical world, the [rrd]{.smallcaps} phenomenon has been termed anything from "moderately rare" to "moderately common." No exact cause or incidence has been documented[@b2-co15_1p053].

D'Angio and colleagues originally documented [rrd]{.smallcaps} in 1959 [@b3-co15_1p053]; the trigger for the abnormal reaction was dactinomycin [@b1-co15_1p053]. Cytotoxics are common instigators [@b1-co15_1p053]. Some medications have been documented to be more commonly involved with [rrd]{.smallcaps}: docetaxel, doxorubicin, gemcitabine, and paclitaxel ([Tables I](#tI-co15_1p053){ref-type="table"} and [II](#tII-co15_1p053){ref-type="table"}). Although the association is only a loose one, Camidge and Price proposed that more-severe skin reactions are more common when the period between radiation and the recall-triggering drug is smaller [@b1-co15_1p053]. According to Putnik *et al.* [@b60-co15_1p053], the median time between the conclusion of radiation treatment and the materialization of [rrd]{.smallcaps} is 39 days. In the present case, materialization of the [rrd]{.smallcaps} occurred within 2 days.

Although the precise mechanism of action for [rrd]{.smallcaps} is not known, several mechanisms that may, or may not, lead to the development of radiation recall have been proposed. These mechanisms include changes in vascularization, [dna]{.smallcaps} repair, radiation-impaired epithelial function of stem cells, and increased sensitivity to drugs [@b1-co15_1p053]. Corticosteroids have been suggested to have some protective effects [@b61-co15_1p053]. We found that steroids are commonly used in the treatment of external symptoms and with the intention of preventing recurrent reactions during subsequent chemotherapy administration [@b23-co15_1p053],[@b25-co15_1p053],[@b26-co15_1p053],[@b30-co15_1p053],[@b32-co15_1p053],[@b33-co15_1p053],[@b39-co15_1p053],[@b40-co15_1p053],[@b43-co15_1p053],[@b45-co15_1p053],[@b46-co15_1p053],[@b50-co15_1p053],[@b53-co15_1p053],[@b55-co15_1p053],[@b59-co15_1p053],[@b60-co15_1p053].

Most recall reactions have occurred when radiotherapy and chemotherapy are separated by less than 2 months ([Table I](#tI-co15_1p053){ref-type="table"}). The present case demonstrates a maximum time frame of 7 weeks separating radiation and resumption of chemotherapy treatment. Of the total reported cases of [rrd]{.smallcaps} outlined here, only 27% (20/75) demonstrated a duration greater than 7 weeks in terms of time passed between completion of radiotherapy and commencement of chemotherapy [@b1-co15_1p053],[@b5-co15_1p053]--[@b7-co15_1p053],[@b12-co15_1p053],[@b13-co15_1p053],[@b17-co15_1p053],[@b19-co15_1p053],[@b20-co15_1p053],[@b23-co15_1p053],[@b24-co15_1p053],[@b27-co15_1p053],[@b30-co15_1p053],[@b37-co15_1p053],[@b39-co15_1p053],[@b52-co15_1p053],[@b53-co15_1p053],[@b59-co15_1p053].

Although [rrd]{.smallcaps} is a rare phenomenon, it poses a significant barrier to treatment for patients. The condition creates a paradox: patients and clinicians alike wish to proceed with the most desirable treatment in the given circumstances, but are unable to do so because of the rare skin reaction. The present report serves as a reminder to palliative health care professionals of the possible danger of a recall reaction if an insufficient period has passed between radiotherapy and commencement of a potential recall-inducing drug.
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![Retrobulbar metastasis, axial, and coronal computed tomography images with contrast. (A) Axial view of the inferior orbits demonstrates enhancing abnormal soft tissue posterior and lateral to the left globe (arrow). (B) Axial view of the upper orbits demonstrates enhancing abnormal soft tissue in the medial left orbit inseparable from the medial rectus muscle (arrow). (C) Coronal view demonstrates abnormal soft tissue in the medial left orbit inseparable from the medial rectus (arrow) and in the lateral inferior left orbit inseparable from the inferior rectus and in contact with the optic nerve (arrowhead).](co15_1p053f1){#f1-co15_1p053}

###### 

I Radiation recall dermatitis ([rrd]{.smallcaps}): case summaries

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                                              Condition treated                                                                             Radiation dose                                                                                                                                                           Drug leading to [rrd]{.smallcaps}[a](#tfn1-co15_1p053){ref-type="table-fn"}                                                                                 Time to [rrd]{.smallcaps}                                                                                         Treatment [a](#tfn1-co15_1p053){ref-type="table-fn"}
  ---------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tan *et al.*, 1959 [@b4-co15_1p053]                                    Ewing sarcoma of the left hip                                                                 10 Gy to the left knee and 17.5 Gy to the spine                                                                                                                          Dactinomycin (75 μg/kg) 7 days after completion of [rt]{.smallcaps}                                                                                         Unspecified                                                                                                       Unspecified

  D'Angio, 1962 [@b3-co15_1p053]                                         Wilms tumour                                                                                  [rt]{.smallcaps} to the left lung and right paracardiac                                                                                                                  Dactinomycin                                                                                                                                                During administra- tion of response- inducing drug                                                                Unspecified

  Von Essen *et al.*, 1963 [@b5-co15_1p053]                              Breast carcinoma                                                                              30 Gy                                                                                                                                                                    5-Fluorouracil (15 mg/kg daily for 4 days) 7 weeks after [rt]{.smallcaps}                                                                                   2 Weeks                                                                                                           Unspecified

  Sears, 1964 [@b6-co15_1p053]                                           Wilms tumour                                                                                  Postsurgical tumour-bed irradiation                                                                                                                                      Hydroxyurea (60 mg/kg daily) 1 month after [rt]{.smallcaps}                                                                                                 5 Days                                                                                                            Unspecified

                                                                         Wilms tumour                                                                                  Radiation for pulmonary metastasis                                                                                                                                       Hydroxyurea (60 mg/kg daily) 1 month after [rt]{.smallcaps}                                                                                                 9 Days                                                                                                            Unspecified

                                                                         Rhabdomyosarcoma of the cervical area                                                         30 Gy                                                                                                                                                                    Hydroxyurea (60 mg/kg daily) 47 days after [rt]{.smallcaps}                                                                                                 8 Days                                                                                                            Unspecified

                                                                         Rhabdomyosarcoma of the cervical area                                                         16 Gy to site of pulmonary metastasis                                                                                                                                    Hydroxyurea (60 mg/kg daily) 7 days after [rt]{.smallcaps}                                                                                                  16 Days                                                                                                           Unspecified

  Lampkin, 1969 [@b7-co15_1p053]                                         Rhabdomyosarcoma of the right middle ear                                                      56.44 Gy to the right face 28.32 Gy to the left side                                                                                                                     Vinblastine (0.2 mg/kg) 2 months after [rt]{.smallcaps}                                                                                                     1 Day                                                                                                             Unspecified; same reaction occurred 2 weeks later

  Jaffe *et al.*, 1973 [@b8-co15_1p053]                                  Osteogenic sarcoma                                                                            26.25 Gy                                                                                                                                                                 Methotrexate (400 mg/kg) 24 hours after [rt]{.smallcaps}                                                                                                    Unspecified                                                                                                       Unspecified; rechallenged 2--3 weeks later with no recurrence

  Donaldson *et al.*, 1974 [@b9-co15_1p053]                              Fibrosarcoma of the right mandible                                                            59.5 Gy                                                                                                                                                                  Doxorubicin (Adriamycin: 60 mg/m^2^) 5 weeks after [rt]{.smallcaps}                                                                                         7 Days                                                                                                            Unspecified; rechallenged at weeks 7 and 15 at the same and reduced doses with identical reaction

                                                                         Osteosarcoma of the fibula                                                                    59.5 Gy                                                                                                                                                                  Doxorubicin (Adriamycin: 60 mg/m^2^) 1 week after [rt]{.smallcaps}                                                                                          7 Days                                                                                                            Unspecified; rechallenged after 12 weeks with identical reaction

  Etcubanas and Wilbur, 1974 [@b10-co15_1p053]                           Mandibular fibrosarcoma                                                                       Unspecified                                                                                                                                                              Doxorubicin (Adriamycin: 60 mg/m^2^) 4 weeks after [rt]{.smallcaps}                                                                                         Unspecified                                                                                                       Unspecified; after second cycle, a milder skin reaction occurred

                                                                         Unspecified                                                                                   Unspecified                                                                                                                                                              Doxorubicin (Adriamycin: 60 mg/m^2^) 1 week after [rt]{.smallcaps}                                                                                          Unspecified                                                                                                       Unspecified; rechallenged twice, with identical reaction each time

  Cassady *et al.*, 1975 [@b11-co15_1p053]                               Lymphoma to the right axilla and supraclavicular fossa                                        12 Gy to mantle field                                                                                                                                                    Doxorubicin (Adriamycin: 75 mg/m^2^) 26 days after [rt]{.smallcaps}                                                                                         Hours                                                                                                             Unspecified

                                                                         Osteosarcoma to the left proximal humerus                                                     24 Gy                                                                                                                                                                    Doxorubicin (Adriamycin: 30 mg/m^2^ daily for 3 days) 18 days after [rt]{.smallcaps}                                                                        7 Days                                                                                                            Unspecified

  Rosen *et al.*, 1975 [@b12-co15_1p053]                                 Osteogenic sarcoma                                                                            16 Gy                                                                                                                                                                    Methotrexate (200 mg/kg) 8 weeks after [rt]{.smallcaps}                                                                                                     5 Days                                                                                                            Unspecified; rechallenged twice with similar reactions

  Mayer *et al.*, 1976 [@b13-co15_1p053]                                 Metastatic breast cancer                                                                      45 Gy to the spine                                                                                                                                                       Doxorubicin (Adriamycin: 80 mg/injection, 1 injection per month for 9 months) given 7 years after [rt]{.smallcaps}                                          7 Months (at the time of the 7th injection)                                                                       Unspecified

  Fontana, 1979 [@b14-co15_1p053]                                        Small-cell lung cancer                                                                        38 Gy                                                                                                                                                                    Etoposide (100 mg/m^2^ on days 1--3) 7 days after [rt]{.smallcaps}                                                                                          18 Hours                                                                                                          Unspecified; rechallenged 3 weeks later, resulting in the same reaction

  Solberg *et al.*, 1980 [@b15-co15_1p053]                               Acute myelomonocytic leukemia and leukemia cutis                                              21 Gy whole-body irradiation                                                                                                                                             Doxorubicin (Adriamycin: 35 mg/m^2^ daily for 3 days) given 2 days after [rt]{.smallcaps}                                                                   4 Days                                                                                                            Death related to toxicity

  Weiss *et al.*, 1986 [@b16-co15_1p053]                                 Advanced cancers                                                                              Unspecified                                                                                                                                                              Intravenous trimetrexate (80 mg/m^2^ over 24 hours) every 28 days                                                                                           Unspecified                                                                                                       Unspecified

                                                                                                                                                                       Unspecified                                                                                                                                                              Intravenous trimetrexate (200 mg/m^2^ over 24 hours) every 28 days                                                                                          Unspecified                                                                                                       Unspecified

                                                                                                                                                                       Unspecified                                                                                                                                                              Intravenous trimetrexate (200 mg/m^2^ over 24 hours) every 28 days                                                                                          Unspecified                                                                                                       Unspecified

                                                                                                                                                                       Unspecified                                                                                                                                                              Intravenous trimetrexate (200 mg/m^2^ over 24 hours) every 28 days                                                                                          Unspecified                                                                                                       Unspecified

  Jolivet *et al.*, 1987 [@b17-co15_1p053]                               Lung cancer                                                                                   40 Gy                                                                                                                                                                    Trimetrexate (2 mg/m^2^ bolus) for 9 consecutive days every 28 days for 2 cycles; begun 10 months after completion of [rt]{.smallcaps}                      Unspecified                                                                                                       Unspecified

  Kellie *et al.*, 1987 [@b18-co15_1p053]                                Embryonal rhabdomyosarcoma of the legs                                                        54 Gy                                                                                                                                                                    Melphalan (200 mg/m^2^) 6 weeks after completion of [rt]{.smallcaps}                                                                                        24 Hours                                                                                                          Unspecified

  Nemechek and Corder, 1992[@b19-co15_1p053]                             Man (age 34) with [hiv]{.smallcaps} and a large Kaposi sarcoma lesion on the left foot        27 Gy in 15 fractions                                                                                                                                                    Intravenous vinblastine (10 mg/m^2^), begun 10 months after [rt]{.smallcaps}                                                                                48 Hours                                                                                                          Healed by the 5th day after chemotherapy

  Parry, 1992 [@b20-co15_1p053]                                          Woman (age 70) with breast cancer                                                             Wide local excision and adjuvant [rt]{.smallcaps} 2 years earlier                                                                                                        Tamoxifen (20 mg daily) started 2 years after [rt]{.smallcaps}                                                                                              5 Days                                                                                                            Discontinued tamoxifen; resolved in 2 weeks; rechallenged at 10 mg daily, with mild recurrence

  Raghavan *et al.*, 1993 [@b21-co15_1p053]                              Recurrent breast carcinoma                                                                    61.2 Gy to the chest wall; 65.3 Gy to the supraclavicular region                                                                                                         Paclitaxel (130 mg/m^2^ over 24 h), begun 2 days after [rt]{.smallcaps}                                                                                     5 Days                                                                                                            Antibiotics, chest wall debridement

  Stelzer *et al.*, 1993[@b22-co15_1p053]                                [aids]{.smallcaps}-related Kaposi sarcoma                                                     Each lesion randomized to 1 of 3 possible radiation fractionation schemes:1) 40 Gy in 20 fractions2) 40 Gy in 20 fractions3) 8 Gy in 1 fraction4) 20 Gy in 5 fractions   Intravenous bleomycin (10 mg/m^2^) on a weekly basis                                                                                                        1\) 3 Days after second injection2) 3 Days after second injection3) No [rrd]{.smallcaps}4) No [rrd]{.smallcaps}   In 1) and 2), exacerbated by oral etoposide therapy started 4 days after appearance of the skin reaction

  Shenkier and Gelman, 1994, as cited by                                 Advanced gastric cancer                                                                       44 Gy                                                                                                                                                                    Paclitaxel (90 mg/m^2^) 7 months after [rt]{.smallcaps}                                                                                                     3 Hours                                                                                                           Mild recurrence when paclitaxel given in 7 further cycles

  Camidge and Price, 2001 [@b1-co15_1p053]                               Advanced gastric cancer                                                                       44 Gy                                                                                                                                                                    Paclitaxel (90 mg/m^2^) 8 months after [rt]{.smallcaps}                                                                                                     6 Hours                                                                                                           No recurrence when paclitaxel given in 7 further cycles

  Abadir and Liebmalen 1995 [@b23-co15_1p053]                            Woman (age 60) with adenocarcinoma of the gallbladder                                         Tumour dose was 61.2 Gy in 34 fractions                                                                                                                                  Simvastatin for hypercholesterolemia (20 mg daily), 11 months after [rt]{.smallcaps}                                                                        2--3 Days                                                                                                         Prednisone and cephalotin

  Extermann *et al.*, 1995 [@b24-co15_1p053]                             Man (age 55) with ductal carcinoma of the right breast                                        Tamoxifen (20 mg daily), plus 48.25 Gy with a 15-Gy boost to the tumour bed                                                                                              Isoniazid 400 mg, plus rifampicin 600 mg, plus pyrazinamide 2 mg to treat nasopharyngeal tuberculosis, 4 months after [rt]{.smallcaps}                      During 4th week of treatment                                                                                      All medications were continued, and the reaction gradually regressed in the weeks following

  Perez *et al.*, 1995 [@b25-co15_1p053]                                 Woman (age 32) with metastatic breast cancer                                                  30 Gy to the lumbar spine                                                                                                                                                Edatrexate (100 mg/m^2^ biweekly), begun 6 weeks after [rt]{.smallcaps}                                                                                     After 3 doses (11 days)                                                                                           Topical therapy, [nsaids;]{.smallcaps} rechallenged with prednisone with mild recurrence

  Phillips, 1995, as cited by Camidge and Price, 2001 [@b1-co15_1p053]   Unknown                                                                                       25 Gy                                                                                                                                                                    Paclitaxel (90 mg/m^2^) given 27 days after [rt]{.smallcaps}                                                                                                3 Days                                                                                                            No recurrence when paclitaxel given in 3 further cycles

  Schweitzer *et al.*, 1995 [@b26-co15_1p053]                            Woman (age 61) with metastatic lung adenocarcinoma                                            43.2 Gy to the mediastinum; 46 Gy to the ribs                                                                                                                            Paclitaxel (175 mg/m^2^ over 3 hours), begun 12 days after [rt]{.smallcaps} completion                                                                      Hours                                                                                                             Dexamethasone (Decadron: 20 mg), diphenhydramine (50 mg); paclitaxel given with Decadron after 2 weeks with no recurrence

  Bokenmeyer *et al.*, 1996 [@b27-co15_1p053]                            Woman (age 55) with breast cancer                                                             50 Gy to the breast; 54 Gy to the lymph nodes                                                                                                                            Paclitaxel (175 mg/m^2^ over 3 h), 13 months after [rt]{.smallcaps}                                                                                         5 Days                                                                                                            Discontinuation of paclitaxel

  McCarty *et al.*, 1996 [@b28-co15_1p053]                               Woman (age 51) with invasive lobular breast carcinoma                                         50.4 Gy in 28 fractions; mild skin erythema developed                                                                                                                    Paclitaxel (200 mg/m^2^), 7 days after [rt]{.smallcaps}                                                                                                     4 Days                                                                                                            Healing within 10 days; treatment unspecified

  Yeo *et al.*, 1997 [@b29-co15_1p053]                                   Woman (age 51) with breast cancer                                                             30 Gy in 10 fractions to T10--L4 spine and pelvis                                                                                                                        Docetaxel (100 mg/m^2^) on 3-weekly basis and prior oral dexamethasone (Decadron) for 5 days                                                                4 Days after second injection                                                                                     Dose reduction; no recurrence of [rrd]{.smallcaps}

  Bostrom *et al.*, 1999 [@b30-co15_1p053]                               Woman (age 48) with highly differentiated tuboloductal breast cancer                          54 Gy                                                                                                                                                                    Tamoxifen (20 mg/m^2^ daily) 28 months after [rt]{.smallcaps}                                                                                               2 Months                                                                                                          Local steroid cream, mometasone furoate, once daily for 10 days; skin appeared normal 7 weeks after discontinuing tamoxifen; after 8 weeks, restarted on toremifene without recurrence

  Wilson *et al.*, 1999 [@b31-co15_1p053]                                Woman (age 46) with breast cancer                                                             Unspecified                                                                                                                                                              Epirubicin                                                                                                                                                  2 Weeks                                                                                                           Surgical debridement and microvascular free-flap reconstruction

  Camidge & Kunkler, 2000 [@b32-co15_1p053]                              Woman (age 50) with breast cancer                                                             50 Gy in 20 fractions                                                                                                                                                    Cycle 2 of docetaxel (100 mg/m^2^) with dexamethasone (Decadron: 8 mg once daily for 3 days), 16 days after end of [rt]{.smallcaps}                         Within 7 days                                                                                                     Docetaxel reduced to 75% and given 21 days later; steroids for 7 days without recurrence

  Castellano *et al.*, 2000 [@b33-co15_1p053]                            Man (age 61) with stage [iv nsclc]{.smallcaps}                                                24 Gy in 8 fractions                                                                                                                                                     Gemcitabine (1250 mg/m^2^ on days 1, 8, 15 per 28-day cycle) 4 weeks after completion of [rt]{.smallcaps}                                                   8 Days (second dose)                                                                                              Oral dexamethasone (Decadron) and diphenhydramine; resolved 10 days later; treatment continued with other chemotherapies

  Giesel *et al.*, 2000 [@b34-co15_1p053]                                Woman with breast cancer                                                                      Whole-brain irradiation: 2 Gy for 5 days weekly, up to 50 Gy                                                                                                             Docetaxel restarted (30 mg/m^2^ weekly)                                                                                                                     Unspecified                                                                                                       Unspecified

                                                                         Woman with breast cancer                                                                      Whole-brain irradiation: 2 Gy for 5 days weekly, for up to 50 Gy                                                                                                         Docetaxel re-started (100 mg/m^2^ weekly)                                                                                                                   Unspecified                                                                                                       Unspecified

  Kharfan *et al.*, 2000 [@b35-co15_1p053]                               Woman (age 25) with stage [iv]{.smallcaps} nodular sclerosis Hodgkin disease                  30 Gy to lumbar spine and right proximal femur                                                                                                                           Methotrexate (10 mg/m^2^ on day +1 after bone marrow transplant; 15 mg/m^2^ on days +3, +6, and +11)                                                        7 Days after transplant                                                                                           Hydrating emulsions (treated symptomatically)

  Chan *et al.*, 2001 [@b36-co15_1p053]                                  Man (age 50) with a sigmoid carcinoma                                                         41.4 Gy in 23 days                                                                                                                                                       Oxaliplatin-based chemotherapy (oxaliplatin, plus 5-fluorouracil, plus folinic acid), resumed 8 days after completion on [rt]{.smallcaps}                   3 Days                                                                                                            Aqueous cream and sodium fusidate ointment (Fucidin); chemotherapy discontinued and reaction settled after 2 weeks; 5-fluorouracil plus folinic acid alone resumed without recurrence

  Kennedy and McAleer, 2001 [@b37-co15_1p053]                            Malignant melanoma to the right temple                                                        30 Gy                                                                                                                                                                    Dacarbazine (800 mg/m^2^ once every 3 weeks), begun 2 months after [rt]{.smallcaps}                                                                         10 Days                                                                                                           Unspecified

  Bar-Sela *et al.*, 2001 [@b38-co15_1p053]                              Man (age 65) with lung adenocarcinoma                                                         RT to mediastinum and upper lobe                                                                                                                                         Gemcitabine                                                                                                                                                 Unspecified                                                                                                       Unspecified

  Jeter *et al.*, 2002 [@b39-co15_1p053]                                 Woman (age 41) with breast cancer                                                             30 Gy in 10 fractions to lumbar spine                                                                                                                                    Gemcitabine (1000 mg/m^2^ every 2 weeks), plus trastuzumab (Herceptin) weekly for 4 weeks, 5.5 months after [rt]{.smallcaps}                                2 Weeks                                                                                                           Discontinuation of gemcitabine slowly resolved the skin reaction

                                                                         Man (age 79) with [nsclc]{.smallcaps}                                                         30 Gy in 10 fractions                                                                                                                                                    Gemcitabine (1000 mg/m^2^)\                                                                                                                                 10 Days                                                                                                           Supportive care, alginate gel pads, bowel rest
                                                                                                                                                                                                                                                                                                                                                11 days after [rt]{.smallcaps}                                                                                                                                                                                                                                                

                                                                         Woman (age 63) with metastatic adenocarcinoma of unknown primary                              30 Gy in 10 fractions, plus 25 Gy in 2 fractions (boost)                                                                                                                 Gemcitabine (1000 mg/m^2^), 3.4 months after [rt]{.smallcaps}                                                                                               3 Days                                                                                                            Intravenous steroids for 2 days with minimal response

  Morkas *et al.*, 2002 [@b40-co15_1p053]                                Woman (age 39) with infiltrating ductal carcinoma                                             50.4 Gy in 28 fractions, plus 10 Gy to tumour bed and 2 cm surrounding                                                                                                   Docetaxel (100 mg/m^2^), plus prophylactic dexamethasone (Decadron)                                                                                         10 Days                                                                                                           Methylprednisone (80 mg twice daily); docetaxel at 75% induced a less severe reaction

  Ortmann and Hohenberg, 2002 [@b41-co15_1p053]                          Woman (age 56) with breast cancer                                                             30 Gy in 10 fractions to right hip                                                                                                                                       Capecitabine (2000 mg twice daily for 14 days)                                                                                                              3 Days after completion of first course                                                                           Unspecified

  Piroth *et al.*, 2002 [@b42-co15_1p053]                                Woman (age 40) with breast cancer                                                             30.9 Gy upper-body irradiation, plus whole-brain and pelvis                                                                                                              Docetaxel (30 mg/m^2^) started 1 week after [rt]{.smallcaps}                                                                                                14 Days                                                                                                           Discontinuation and anti-inflammatory agents

  Thomas and Stea, 2002 [@b43-co15_1p053]                                Woman (age 29) with malignant melanoma of the scalp                                           Excision, plus biweekly treatments of 6 Gy, totalling 30 Gy                                                                                                              Intravenous interferon alfa-2b (20×10^9^ IU) administered 5 days after completion of [rt]{.smallcaps}                                                       6 Days                                                                                                            Occlusive dressings with wound gel; resolved in 7 days

  Ee and Yosipovitch, 2003 [@b44-co15_1p053]                             Woman (age 55) with metastatic breast cancer                                                  Photo-recall                                                                                                                                                             Chemotherapy with taxanes                                                                                                                                   Unspecified                                                                                                       Unspecified

  Jimeno *et al.*, 2003 [@b45-co15_1p053]                                Woman (age 53) with stage IV infiltrating ductal carcinoma                                    30 Gy to left femur                                                                                                                                                      Pegylated liposomal doxorubicin (40 mg/m^2^ on day 1 every 28 days), 4 weeks after completion of [rt]{.smallcaps}                                           12 Days                                                                                                           Topical steroids (betamethasone dipropionate); completely resolved 14 days later

  Keung *et al.*, 2003 [@b46-co15_1p053]                                 Woman (age 49) with breast cancer                                                             50 Gy in 25 fractions following modified mastectomy                                                                                                                      Arsenic trioxide (0.15 mg/kg daily), for 5 days each week for 5 weeks                                                                                       Day 2 of week 3                                                                                                   Arsenic trioxide discontinued, topical triamcinolone/silver sulfadiazine cream started

  Schwartz *et al.*, 2003 [@b47-co15_1p053]                              Woman (age 37) with recurrent ovarian adenocarcinoma                                          Palliative whole-pelvis [rt]{.smallcaps}: 45 Gy in 25 fractions                                                                                                          3 Months later, started on gemcitabine (800 mg/m^2^), every other week; reduced to 600 mg/m^2^ because of severe neutropenia                                Unspecified                                                                                                       Ciprofloxacin (250 mg twice daily) with slight improvement; 2nd cycle after 2 weeks produced the same reaction within 24 hours

  Muggia, 2004[@b48-co15_1p053]                                          Woman with breast cancer                                                                      [rt]{.smallcaps} to supraclavicular, internal mammary, and axillary areas                                                                                                Doxorubicin with weekly trastuzumab                                                                                                                         2--4 Weeks                                                                                                        None; continued liposomal doxorubicin

  Singer *et al.*, 2004 [@b49-co15_1p053]                                Woman (age 88) with infiltrating ductal carcinoma                                             50.4 Gy, plus 10 Gy to tumour bed                                                                                                                                        Tamoxifen (20 mg daily)                                                                                                                                     3 Months                                                                                                          None; continued on tamoxifen; completely resolved 3 months later

  Borgia *et al.*, 2005 [@b50-co15_1p053]                                Woman (age 63) with infiltrating ductal carcinoma                                             50 Gy over 5 weeks                                                                                                                                                       Docetaxel (100 mg/m^2^), every 3 weeks started 1 week after [rt]{.smallcaps}                                                                                4 Days after second course                                                                                        Oral methylprednisone resulted in 10-day complete remission

  Kandemir *et al.*, 2005 [@b51-co15_1p053]                              Woman (age 55) with breast cancer                                                             50 Gy over 5 weeks                                                                                                                                                       Docetaxel (100 mg/m^2^), plus oral dexamethasone (Decadron) for 3 days                                                                                      11 Days                                                                                                           None; complete resolution after 6 days; continued docetaxel with no recurrence

  Marisavljevic *et al.*, 2005 [@b52-co15_1p053]                         Woman (age 32) with stage [iib]{.smallcaps} Hodgkin lymphoma                                  Total dose of 60 Gy                                                                                                                                                      Gemcitabine (1250 mg/m^2^ on days 1, 8, 15), plus oral dexamethasone (Decadron: 8 mg on days 1, 2, 8, 9, 15, 16) more than 2 years after [rt]{.smallcaps}   2 Days                                                                                                            Skin reaction faded over 10 days without specific treatment; mild recurrence after each gemcitabine administration

  Ash and Videtic, 2006 [@b53-co15_1p053]                                Woman (age 56) with infiltrating ductal carcinoma                                             50 Gy in 25 fractions, plus additional 10 Gy in 5 fractions to lumpectomy site                                                                                           Phentermine 1 year after [rt]{.smallcaps}                                                                                                                   Unspecified                                                                                                       Prednisone 30 mg daily for 2 weeks; minimal discolouration after 4 weeks

  Ayoola and Lee, 2006 [@b54-co15_1p053]                                 Woman (age 54) with lung squamous cell carcinoma                                              64.8 Gy to thorax and mediastinum                                                                                                                                        Cefotetan upon admission to hospital for cholecystitis                                                                                                      3 Days                                                                                                            Cefotetan withdrawn; free of pain in 4 days

  Barlesi *et al.*, 2006 [@b55-co15_1p053]                               Woman (age 75) with primary lung adenocarcinoma; treated for breast cancer 27 years earlier   Lumpectomy and adjuvant radiation to the breast 27 years earlier                                                                                                         Pemetrexed (500 mg/m^2^); oral prednisone (40 mg) twice daily the day before, the day of, and the day after chemotherapy                                    3 Days                                                                                                            Steroids (prednisone 1 mg/kg daily); improvement in 48 hours; resolution at 2 weeks

  Fakih, 2006 [@b56-co15_1p053]                                          White man (age 52) with pancreatic adenocarcinoma                                             1.8 Gy daily for 50.4 Gy total                                                                                                                                           Gemcitabine (1000 mg/m^2^), for 3 weeks every 4-week-cycle                                                                                                  Cycle 5                                                                                                           Withdrawal of gemcitabine resulted in spontaneous resolution

  Kaya *et al.*, 2006 [@b57-co15_1p053]                                  Woman (age 41) with non-Hodgkin lymphoma                                                      UV radiation                                                                                                                                                             Methotrexate (high dose), plus cytarabine (high dose)                                                                                                       Unspecified                                                                                                       Cold compress; lesions resolved within a week (with hyperpigmentation)

  Kundranda and Daw, 2006 [@b58-co15_1p053]                              Woman (age 48) with well-differentiated infiltrating ductal carcinoma                         50 Gy with a boost of 14 Gy to the tumour bed                                                                                                                            Tamoxifen (20 mg daily)                                                                                                                                     Within 1 week                                                                                                     Oral cephalexin did not provide relief; tamoxifen discontinued, diphenhydramine given; after 12 weeks, restarted on tamoxifen with mild itchiness, but no recurrence

  Mizumoto *et al.*, 2006 [@b59-co15_1p053]                              Woman (age 76) with diffuse large B cell lymphoma of the left neck                            36 Gy in 18 fractions to the left neck                                                                                                                                   Docetaxel (60 mg/m^2^) every 3 weeks 1 year after [rt]{.smallcaps}                                                                                          6 Days                                                                                                            Gargle with a local anesthetic and topical corticosteroids; 80% of docetaxel dose was given 2 weeks later; milder recall phenomenon recurred after 1 week

                                                                         Woman (age 60) with breast cancer                                                             50 Gy in 20 fractions                                                                                                                                                    Docetaxel (30 mg/m^2^ weekly) restarted 14 days after [rt]{.smallcaps}                                                                                      Day 6 after second course of chemotherapy                                                                         Topical corticosteroids; continued docetaxel therapy for 9 cycles

  Putnik *et al.*, 2006 [@b60-co15_1p053]                                Man (age 65) with squamous cell carcinoma of the epiglottis                                   64.8 Gy                                                                                                                                                                  Hypericin                                                                                                                                                   4 Weeks after [rt]{.smallcaps}, then again 1 year after [rt]{.smallcaps}                                          Symptoms controlled by steroid cream, but disappeared only when hypericin was discontinued

  Hird *et al.*, 2007 (present article)                                  Woman (age 55) with metastatic breast adenocarcinoma                                          1\) 20 Gy in 5 fractions to the thoracic spine (October 2006) 2) Whole-brain radiation: 20 Gy in 5 fractions (November 2006)                                             Paclitaxel (175 mg/m^2^) and gemcitabine (1000 mg/m^2^) administered 1.5 weeks after completion of whole-brain radiation                                    2 Days                                                                                                            Silver sulphadiazine cream and hydrocortisone eardrops; discolouration still apparent after 8 weeks; started on [cef]{.smallcaps} with concurrent dexamethasone (Decadron) without recurrence
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Holders of named pharmaceutical trademarks: Adriamycin: Pharmacia, Kalamazoo, MI, U.S.A.; Decadron: Merck and Co., Whitehouse Station, NJ, U.S.A.; Fucidin: Leo Pharma, Ballerup, Denmark; Herceptin: Genentech, San Francisco, CA, U.S.A.

[rt]{.smallcaps} = radiotherapy; [nsaids]{.smallcaps} = nonsteroidal anti-inflammatory drugs; [nsclc]{.smallcaps} = non-small-cell lung cancer; [uv]{.smallcaps} = ultraviolet; [cef]{.smallcaps} = cyclophospha-mide, epirubicin, 5-fluorouracil.

###### 

Radiation recall dermatitis--inducing drugs (*n* = 75)[@b1-co15_1p053],[@b4-co15_1p053]--[@b61-co15_1p053]

  Drug           Frequency   
  -------------- ----------- ----
  Docetaxel      10          13
  Doxorubicin    10          13
  Gemcitabine    8           11
  Paclitaxel     8           11
  Trimetrexate   5           7
  Methotrexate   4           5
  Hydroxyurea    4           5
  Tamoxifen      4           5
  Dactinomycin   2           3
  Vinblastine    2           3
  Others         18          24
